000283088 001__ 283088
000283088 005__ 20251231103633.0
000283088 0247_ $$2doi$$a10.1002/alz70860_099453
000283088 0247_ $$2ISSN$$a1552-5260
000283088 0247_ $$2ISSN$$a1552-5279
000283088 037__ $$aDZNE-2025-01495
000283088 082__ $$a610
000283088 1001_ $$0P:(DE-2719)9000379$$aSchwarck, Svenja$$b0$$eFirst author
000283088 1112_ $$aAlzheimer’s Association International Conference$$cToronto$$d2025-07-27 - 2025-07-31$$gAAIC 25$$wCanada
000283088 245__ $$aRole of physical fitness in resistance and cognitive resilience against age‐related pathology
000283088 260__ $$c2025
000283088 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1767099421_6287
000283088 3367_ $$033$$2EndNote$$aConference Paper
000283088 3367_ $$2BibTeX$$aINPROCEEDINGS
000283088 3367_ $$2DRIVER$$aconferenceObject
000283088 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000283088 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000283088 3367_ $$2ORCID$$aOTHER
000283088 520__ $$aBackground:Cognitive reserve (CR) and brain maintenance enable the brain to maintain performance despite injury and disease while also reducing neural decline by safeguarding brain structure and function. Physical activity is a potential pathway to BM and CR, as fitness relates to better cognition in older adults, though the underlying mechanisms remain unclear. To explore the role of physical fitness in BM and CR, we tested its association with brain pathology and its potential moderation of pathology's impact on cognitive performance.Method:We collected data from 167 cognitively unimpaired participants (mean age 71.57±7.50 years; 70 females) of the ongoing SFB1436 study (www.sfb1435.de; Figure 1). We collected many markers, including global and verbal cognitive performance; aerobic (VO2max) and muscular capacity; blood-based biomarkers of Alzheimer's disease (plasma Aβ1-42/1-40, ptau217) and plasticity (serum BDNF, VEGF and Cathepsin-B); PET-derived medial temporal lobe tau burden (MTL DVR, 18F-PI-2620 PET); and MRI-derived volumes of hippocampi, white matter hyperintensities, and perivascular spaces (PVS) in the basal ganglia (BG) and centrum semiovale regions. The tests were two-fold. We first tested whether fitness was associated with lower MTL DVR values, reduced MRI-derived volumes of brain pathology, and better cognition. Using moderation analysis, we then tested whether physical fitness moderated the relationship between pathology and cognition. We relied on ANOVA for model comparison. We adjusted models for age and sex and FDR-corrected multiple comparisons.Result:Participants with better aerobic capacity (VO2max) had lower BG-PVS volumes (Figure 2a) and better global cognitive performance. Those with higher MTL tau burden had worse verbal memory (Figure 2b). We found no evidence of a relationship between physical fitness and Alzheimer's markers, plasticity-related markers, or hippocampal volume. Moderation analysis revealed that physical fitness did not moderate the relationship between MTL tau burden and verbal memory, but model comparison revealed weak evidence for CR against MTL tau.Conclusion:We demonstrated that aerobic fitness is related to lower BG-PVS volumes in old age and showed that aerobic fitness tends to act as CR proxy against MTL tau pathology. Aerobic fitness may help maintain cerebrovascular and glymphatic dysfunction in old age, thereby mitigating cognitive decline.
000283088 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000283088 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000283088 7001_ $$0P:(DE-2719)9002133$$aBehrenbruch, Niklas$$b1$$udzne
000283088 7001_ $$0P:(DE-2719)9002320$$aSchumann-Werner, Beate$$b2$$udzne
000283088 7001_ $$0P:(DE-2719)9000804$$aVockert, Niklas$$b3$$udzne
000283088 7001_ $$0P:(DE-2719)2811487$$aMüller, Patrick$$b4$$udzne
000283088 7001_ $$0P:(DE-2719)9001989$$aMoyano, Jose Bernal$$b5$$udzne
000283088 7001_ $$0P:(DE-HGF)0$$aDuarte, Roberto$$b6
000283088 7001_ $$0P:(DE-HGF)0$$aHernandez, Maria del C. Valdes$$b7
000283088 7001_ $$0P:(DE-HGF)0$$aWardlaw, Joanna M$$b8
000283088 7001_ $$0P:(DE-2719)2812734$$aGarcia-Garcia, Berta$$b9$$udzne
000283088 7001_ $$0P:(DE-2719)9002356$$aFischer, Larissa$$b10$$udzne
000283088 7001_ $$0P:(DE-2719)9002180$$aMolloy, Eóin N.$$b11
000283088 7001_ $$0P:(DE-2719)2812346$$aHochkeppler, Anne$$b12$$udzne
000283088 7001_ $$0P:(DE-2719)9001517$$aIncesoy, Enise I$$b13$$udzne
000283088 7001_ $$0P:(DE-HGF)0$$aRullmann, Michael$$b14
000283088 7001_ $$aStephens, Andrew W.$$b15
000283088 7001_ $$aPatt, Marianne$$b16
000283088 7001_ $$aBarthel, Henryk$$b17
000283088 7001_ $$aSchildan, Andreas$$b18
000283088 7001_ $$0P:(DE-2719)9003591$$aMarcos Morgado, Barbara$$b19$$udzne
000283088 7001_ $$aEsselmann, Hermann$$b20
000283088 7001_ $$0P:(DE-2719)2811317$$aWiltfang, Jens$$b21$$udzne
000283088 7001_ $$0P:(DE-2719)2814810$$aSabri, Osama$$b22$$udzne
000283088 7001_ $$0P:(DE-2719)2812799$$aKreißl, Michael$$b23$$udzne
000283088 7001_ $$0P:(DE-2719)2000005$$aDüzel, Emrah$$b24$$udzne
000283088 7001_ $$0P:(DE-2719)2811815$$aMaass, Anne$$b25$$eLast author$$udzne
000283088 773__ $$0PERI:(DE-600)2201940-6$$a10.1002/alz70860_099453$$gVol. 21, no. S6, p. e099453$$nS6$$pe099453$$tAlzheimer's and dementia$$v21$$x1552-5260$$y2025
000283088 8564_ $$uhttps://pub.dzne.de/record/283088/files/DZNE-2025-1495.pdf$$yOpenAccess
000283088 8564_ $$uhttps://pub.dzne.de/record/283088/files/DZNE-2025-1495.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000283088 909CO $$ooai:pub.dzne.de:283088$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000379$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002133$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002320$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000804$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811487$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001989$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812734$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002356$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b10$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002180$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b11$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812346$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b12$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001517$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000283088 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003591$$aExternal Institute$$b19$$kExtern
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811317$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b21$$kDZNE
000283088 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2814810$$aExternal Institute$$b22$$kExtern
000283088 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2812799$$aExternal Institute$$b23$$kExtern
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000005$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b24$$kDZNE
000283088 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811815$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b25$$kDZNE
000283088 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000283088 9141_ $$y2025
000283088 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000283088 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000283088 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-06$$wger
000283088 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000283088 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-06
000283088 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000283088 9201_ $$0I:(DE-2719)1311001$$kAG Maaß$$lMultimodal Neuroimaging$$x0
000283088 9201_ $$0I:(DE-2719)5000006$$kAG Düzel$$lClinical Neurophysiology and Memory$$x1
000283088 9201_ $$0I:(DE-2719)1310003$$kAG Müller$$lNeuroprotection$$x2
000283088 9201_ $$0I:(DE-2719)1410006$$kAG Wiltfang$$lMolecular biomarkers for predictive diagnostics of neurodegenerative diseases$$x3
000283088 980__ $$aabstract
000283088 980__ $$aVDB
000283088 980__ $$aUNRESTRICTED
000283088 980__ $$ajournal
000283088 980__ $$aI:(DE-2719)1311001
000283088 980__ $$aI:(DE-2719)5000006
000283088 980__ $$aI:(DE-2719)1310003
000283088 980__ $$aI:(DE-2719)1410006
000283088 9801_ $$aFullTexts